In an elderly patient, can mirtazapine 7.5 mg orally at night be started together with bupropion to improve appetite and sleep?

Yes, mirtazapine 7.5 mg PO nightly can be started with bupropion in elderly patients for appetite and sleep improvement.

Mirtazapine 7.5 mg at bedtime is an appropriate starting dose in elderly patients and is specifically recommended for promoting sleep, appetite, and weight gain, even when used alongside bupropion. 1

Rationale for Combination Therapy

The combination of mirtazapine with bupropion is pharmacologically sound and clinically supported:

• Complementary mechanisms: Bupropion is activating and may cause insomnia 1, while mirtazapine is sedating and promotes sleep 1. This creates a balanced profile where mirtazapine counteracts bupropion's potential sleep disruption.

• Evidence for combination: A randomized controlled trial demonstrated that mirtazapine combined with bupropion achieved a 46% remission rate in major depression, significantly superior to monotherapy 2. The combination was well-tolerated and as safe as single-agent therapy.

• Synergistic effects: Recent data shows bupropion and mirtazapine have distinct, complementary symptom profiles—bupropion excels for hypersomnia, increased appetite, and fatigue, while mirtazapine targets insomnia and decreased appetite 3. This makes them ideal partners when both symptom clusters need addressing.

Dosing Specifics for Elderly

The 7.5 mg dose is actually lower than the standard elderly starting dose but may be advantageous:

• Guidelines recommend mirtazapine starting at 7.5 mg at bedtime with a maximum of 30 mg daily in elderly patients 1
• The FDA label recommends 15 mg as the standard starting dose 4, but lower doses (7.5 mg) have been successfully used in elderly populations to minimize somnolence 5
• In nursing home residents ≥85 years old, mirtazapine was effective and well-tolerated with 72% completing a 12-week trial 6

Expected Benefits

For appetite and sleep specifically:

• Mirtazapine "promotes sleep, appetite, and weight gain" as a documented therapeutic effect 1
• In elderly nursing home residents, mirtazapine produced significant improvements in depression and was associated with mean weight gain of 0.6 kg 6
• Insomnia remission rates reached 62.4% by 6 weeks of treatment 7
• The sedating effects are dose-dependent, with lower doses potentially causing less daytime somnolence 5

Important Safety Considerations

Monitor for these specific issues in elderly patients:

• Somnolence: Occurs in 54% of patients and causes discontinuation in 10.4% 4. Caution patients about activities requiring alertness until tolerance is established. The 7.5 mg dose may reduce this risk compared to 15 mg.

• Weight gain: Appetite increase occurs in 17% of patients, with ≥7% body weight gain in 7.5% 4. This is actually desirable for your indication but monitor if excessive.

• Orthostatic hypotension: Elderly patients have increased sensitivity to cardiovascular effects. Check orthostatic vital signs regularly.

• Hyponatremia risk: Elderly patients, especially those on diuretics or who are volume-depleted, are at higher risk for SIADH 4. Check baseline sodium and monitor if symptoms develop (confusion, weakness, falls).

• No significant drug interactions: Mirtazapine and bupropion do not have clinically significant pharmacokinetic interactions. However, avoid combining with other CNS depressants or alcohol 4.

Contraindications to Rule Out

Before starting, ensure the patient does not have:

• Current MAOI use (requires 14-day washout) 4
• History of hypersensitivity to mirtazapine or DRESS syndrome 4
• Uncontrolled seizure disorder (caution with both agents) 4

Practical Implementation

Start with this approach:

1. Initiate mirtazapine 7.5 mg PO at bedtime (can increase to 15 mg after 1-2 weeks if needed and tolerated) 4
2. Continue current bupropion dosing (ensure second dose is before 3 PM to minimize insomnia) 1
3. Assess response at 2 weeks for sleep and appetite improvement 7
4. If inadequate response at 7.5 mg, increase to 15 mg (standard elderly starting dose)
5. Maximum dose 30 mg daily in elderly 1

Common pitfall to avoid: Don't start at 15 mg if the patient is frail or highly sensitive to sedation—the 7.5 mg dose provides a safer margin while still offering therapeutic benefit for sleep and appetite 5.

The evidence supports this combination as both safe and potentially more effective than either agent alone, with the added benefit of mirtazapine directly addressing the sleep and appetite concerns that bupropion might exacerbate.